FGF21 and metabolic syndrome: Multivariate logistic regression analysis adjusted for age and gender revealed a 0.7% increase in the risk of MetS (adjusted OR 1.007, 95% CI: 1.002–1.011, P=0.004) for every 1 pg/mL increase in FGF21 (Model 1).